Physician profile
Ann E Steel
NPI 1912009713
$1,769.92
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $67.04 · 2021: $101 · 2022: $560 · 2023: $599 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $387.60 | 2021-2024 | Vraylar |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $221.74 | 2022-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $220.23 | 2019-2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $128.82 | 2019-2023 | Trintellix |
| Neos Therapeutics, LP | $104.89 | 2019-2023 | Adzenys Xr-Odt |
| Idorsia Pharmaceuticals US INC | $85.65 | 2022-2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $81.51 | 2019-2023 | Austedo, Austedo Xr |
| Janssen Pharmaceuticals, INC | $77.99 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $71.57 | 2019-2022 | |
| Axsome Therapeutics, INC. | $69.87 | 2022-2024 | Auvelity |
| Neurocrine Biosciences, INC. | $58.79 | 2021-2022 | |
| Corium, LLC | $57.75 | 2022-2023 | Azstarys |
| Adlon Therapeutics L.P. | $45.02 | 2019-2021 | |
| Allergan, INC. | $33.91 | 2019 | |
| Lundbeck LLC | $30.94 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $29.51 | 2022 | |
| Jazz Pharmaceuticals INC. | $22.25 | 2019 | |
| Alkermes, INC. | $21.01 | 2022 | |
| Ironshore Pharmaceuticals INC. | $12.27 | 2020 | |
| Neuronetics, INC. | $8.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Steel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.